Determination of cytarabine and uracil arabinoside in human plasma and cerebrospinal fluid by high-performance liquid chromatography
Authors:
- Henning BreithauptHBHenning Breithaupt
- Jürgen SchickJSJürgen Schick
- 1 September 1981
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 225 (1) , 99-106
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- High dose cytosine arabinoside (HDARAC) in refractory acute leukemiaCancer, 1979
- Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia.British Journal of Clinical Pharmacology, 1979
- Pharmacokinetics of cytosine arabinoside in acute myeloid leukemiaClinical Pharmacology & Therapeutics, 1977
- Drugs Five Years LaterAnnals of Internal Medicine, 1975
- Splenectomy and chemotherapy in acute myelocytic leukemia of childhoodCancer, 1974
- Clinical pharmacology of l‐β‐D‐arabinofuranosyl cytosineClinical Pharmacology & Therapeutics, 1971
- Treatment of adult acute leukemia with arabinosylcytosine and thioguanineCancer, 1969
- Biochemical and pharmacological studies with 1-β-d-arabinofuranosylcytosine in manBiochemical Pharmacology, 1966
- Studies of the enzymatic deamination of cytosine arabinoside—IBiochemical Pharmacology, 1965
- A proposed mechanism of action of 1-β-d-arabinofuranosyl-cytosine as an inhibitor of the growth of leukemic cellsBiochemical Pharmacology, 1962